Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Genor Biopharma Holdings Limited ( (HK:6998) ) has provided an announcement.
Genor Biopharma Holdings Limited has announced the composition of its board of directors, including executive, non-executive, and independent non-executive directors. The board has established three committees: audit, compensation, and nomination, with specific directors assigned to each, which reflects the company’s commitment to strong corporate governance and strategic oversight.
More about Genor Biopharma Holdings Limited
Genor Biopharma Holdings Limited is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. The company is involved in the development and commercialization of innovative biologic therapies, focusing on oncology and autoimmune diseases.
Average Trading Volume: 1,001,468
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.34B
See more insights into 6998 stock on TipRanks’ Stock Analysis page.